thelancet.com
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now
the most common chronic liver disease, affecting up to one in three people in the
general population, with an estimate...